Immuron (IMRN) Current Deferred Revenue (2016 - 2025)
Immuron (IMRN) posted quarterly Current Deferred Revenue of $791391.0 for Q3 2025, down 2.41% on a QoQ basis from $810938.0 in Q4 2024.
Immuron (IMRN) Current Deferred Revenue (2016 - 2025) Analysis & Trends
Immuron (IMRN) has reported Current Deferred Revenue for 9 consecutive years, with $791391.0 the latest figure, recorded in Q3 2025.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $791391.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $791391.0 (changed N/A YoY) and the FY2025 annual result came in at $791391.0, changed N/A from the prior year.
- Current Deferred Revenue declined to $791391.0 in Q3 2025 per IMRN's latest filing, from $810938.0 in the prior quarter.
- Over the last five years, Current Deferred Revenue for IMRN reached as high as $16.4 million in Q4 2022 and fell as low as $14476.2 in Q2 2021.
- A 5-year average of $3.3 million and a median of $455302.3 in 2023 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2021 — Current Deferred Revenue tumbled 98.17% — and 2022, when it jumped 38687.11%.
- Year by year, Current Deferred Revenue stood at $42229.4 in 2021, then soared by 38687.11% to $16.4 million in 2022, then declined by 15.65% to $13.8 million in 2023, then slumped by 94.13% to $810938.0 in 2024, then fell by 2.41% to $791391.0 in 2025.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $791391.0, $810938.0, and $417522.1 for Q3 2025, Q4 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 791,391.00 |
| Dec 31, 2024 | 810,938.02 |
| Jun 30, 2024 | 417,522.15 |
| Sep 28, 2023 | 13.82 Mn |
| Aug 30, 2023 | 398,391.00 |
| Jun 30, 2023 | 493,082.54 |
| Dec 31, 2022 | 16.38 Mn |
| Jun 30, 2022 | 148,156.76 |
| Dec 31, 2021 | 42,229.41 |
| Jun 30, 2021 | 14,476.19 |
| Dec 31, 2020 | 2.31 Mn |
| Dec 31, 2019 | 80,148.00 |
| Dec 31, 2017 | 13,516.43 |
| Sep 28, 2017 | 13,516.43 |
| Aug 31, 2017 | 19,139.00 |
| Jun 30, 2017 | 19,139.00 |
| Dec 31, 2016 | 2.59 Mn |